POAI - predictive-oncology.com Operating income before deduction of amortization
The combination of a unique biobank and the CoMet AI platform creates a barrier to entry for competitors, while molecule discovery partnerships drive future growth for Predictive Oncology (POAI). On the EBITDA chart provided by the GURU.Markets platform, 0.00 represents the current metric. Ultimately, the company's strategy focuses on accelerating pharmaceutical trials and minimizing risks in the development of new drugs.
Summary analytical data breakdowns for Predictive Oncology Inc. (POAI)
- stock quotes and analyst forecast:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
Aggregate Debt to Capital Predictive Oncology|POAI - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Predictive Oncology Inc|POAI - Company Total Debt|Debts to Book Capitalization Predictive Oncology|POAI - Company Long-Term Debt|Company Current Liabilities Predictive Oncology|Immediate Liquidity predictive-oncology.com
- earnings and valuation multiples indicators:
POAI - Company Net Income|Net Profit Forecast Predictive Oncology|POAI - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Predictive Oncology Inc|POAI - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Predictive Oncology|POAI - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Predictive Oncology|POAI - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months predictive-oncology.com|POAI - Earnings growth in current year|Expected net earnings per share growth next year Predictive Oncology
Fundamental company valuation:POAI (Predictive Oncology)
This indicator measures real cash flow from core operations before taxes and interest payments, reflecting the internal efficiency of the business during periods of market volatility. An analysis of absolute EBITDA allows for an assessment of the resilience of Predictive Oncology (POAI), where steady growth of this metric confirms the demand for B2B subscriptions to its AI platform for oncology research among pharmaceutical behemoths.
Competitors of Predictive Oncology (POAI)
Income before deduction of interest, taxes and amortization ISRG|Danaher Corp. - Operating profit EBITDA|Operating income before deduction of amortization bd.com BDX|STERIS (STE) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WST|Profit before payment of interest, taxes and amortization Baxter Corp|Masimo Inc. (MASI) - Operating income before deduction of amortization|Operating profit before deduction of amortization STVN (Stevanato Group S.p.A.)|Company profit before taxes, interest and amortization TFX|Profit before payment of interest, taxes and amortization Merit Medical MMSI|Income before deduction of interest, taxes and amortization NVST|ICUI: Operating profit before deduction of amortization|XRAY - Operating profit EBITDA|LeMaitre Vascular, Inc. (LMAT) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization atricure.com|STAA (STAAR Surgical) - Operating profit EBITDA|Profit before interest, taxes and amortization ChromaDex Corp NAGE|Profit before payment of interest, taxes and amortization ZimVie Dental (ZIMV)|AngioDynamics Inc. - Operating profit before amortization|Cerus Corporation - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization TKNO (teknova.com)|MGRM - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Sharps Technology, Inc. STSS|infusystem.com (INFU) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization UTMD (Utah Med)|Profit before payment of interest, taxes and amortization KORU Medical Systems, Inc.|NYXH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MBOT|PDEX - Profit before interest, taxes and amortization|Operating profit EBITDA ZTEK (Zentek Limited)|ELUT: Operating profit before amortization|Milestone Scientific - Operating profit EBITDA|Operating income before deduction of amortization nexgel.com NXGL|RVP: Operating profit EBITDA|Operating profit before deduction of amortization harvardbioscience.com|Operating profit before deduction of amortization FEMY|MHUA (Meihua Medical) - Company profit before taxes, interest and amortization|Operating profit EBITDA CJMB|Operating income before deduction of amortization atrioncorp.com|NeuroMetrix - Operating profit before deduction of amortization
